Jeffrey S. Hatfield serves as Executive at Vitae Pharmaceuticals, Inc, where they oversee executive responsibilities. Since joining the company, Jeffrey S. Hatfield has executed 16 insider transactions totaling $1.4M, demonstrating a bearish approach to their equity position. Their most recent transaction on May 30, 2024 involved receiving (via award) 8,000 shares valued at $0.
Jeffrey S. Hatfield currently holds 23,806 shares of Vitae Pharmaceuticals, Inc (VTAE), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Jeffrey S. Hatfield has been a net seller of VTAE stock. They have purchased $0 and sold $1.4M worth of shares.
Jeffrey S. Hatfield's most recent insider trade was on May 30, 2024, when they sold 8,000 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |
| May 23, 2022 | VIR | $0 | Award | 6,405 | $N/A | Discretionary |
| May 21, 2021 | VIR | $0 | Award | 3,374 | $N/A | Discretionary |
| Oct 24, 2016 | VTAE | $5.1M | Tender | 244,996 | $21.00 | Discretionary |
| Sep 14, 2016 | VTAE | $1.0M | Sale | 50,000 | $20.81 | Discretionary |
| Apr 29, 2016 | VTAE | $4.6K | Award | 747 | $6.11 | Discretionary |
| Dec 28, 2015 | VTAE | $91.6K | Option Exercise | 26,537 | $3.45 | Discretionary |
| Dec 28, 2015 | VTAE | $91.6K | Option Exercise | 26,537 | $3.45 | Discretionary |
| Dec 23, 2015 | VTAE | $19.3K | Option Exercise | 5,584 | $3.45 | Discretionary |
| Dec 23, 2015 | VTAE | $58.4K | Option Exercise | 16,940 | $3.45 | Discretionary |
| Dec 23, 2015 | VTAE | $382.9K | Sale | 22,524 | $17.00 | Discretionary |
| Mar 13, 2015 | VTAE | $1.9M | Payment | 171,156 | $11.16 | Discretionary |
| Mar 6, 2015 | VTAE | $9.3K | Option Exercise | 8,115 | $1.15 | Discretionary |
| Jan 22, 2015 | VTAE | $9.3K | Option Exercise | 8,115 | $1.15 | Discretionary |
| Jan 22, 2015 | VTAE | $35.6K | Option Exercise | 30,982 | $1.15 | Discretionary |